![Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z]](https://i0.wp.com/cedclinic.com/wp-content/uploads/2026/09/ced-pexels-13091435.jpg?resize=150%2C150&ssl=1 "Autism And Cbd: What Science Says About Hemp Therapy [FItVIfuYe3z] 26")
Reps. Titus, Omar Introduce the Higher Education Marijuana Research Act
Expanded cannabis research access is critical to overcoming federal barriers that limit evidence-based cannabis medicine. The Higher Education Marijuana Research Act aims to expand university research capacity. This development could improve dosing…
Reps. Omar, Titus Introduce the Higher Education Marijuana Research Act
The Higher Education Marijuana Research Act addresses federal barriers limiting academic cannabis research. This legislation could accelerate evidence-based treatment protocols. It aims to bridge the gap between real-world cannabis use and clinical…
Missouri Prepares to Open Unlimited Marijuana Research Licenses – Springfield News-Leader
Missouri cannabis research licenses are set to open unlimited access, removing previous restrictions on academic and clinical studies. This policy change could accelerate controlled research addressing current evidence gaps in cannabis medicine. Expanded…
Explore Cannabis Research Employment Opportunities in California
Cannabis research employment opportunities in California are expanding rapidly due to increased institutional investment. This growth supports workforce development essential for advancing evidence-based cannabis medicine. Job listings highlight the…
Medicinal Cannabis Matters: Friday Roundup – 17 April 2026 | Medicann
The Medicinal Cannabis Matters Friday Roundup 17 April 2026 highlights notable clinical interest in emerging cannabis findings. This roundup covers medical cannabis news, clinical evidence, and healthcare policy updates. Clinicians benefit from…
Cannabis Sales High in Michigan, but Research Barriers Persist
2026 cannabis research barriers limit clinical evidence despite high cannabis sales in Michigan. Federal restrictions create a gap impacting patient safety and treatment optimization. Clinicians face challenges advising patients without robust research…
Missouri Advances State Licensed Cannabis Research Programs
Missouri is advancing state licensed cannabis research to generate clinically relevant data on dosing, safety, and efficacy. This initiative allows studies on real-world cannabis products used by patients. State licensed cannabis research programs…
UW Study Explores Cannabis Use Concerns: HealthLink Insights
This university cannabis research study examines patient concerns about cannabis use with strong clinical evidence. It provides valuable insights for healthcare providers on safety and education. The study helps bridge gaps in understanding cannabis…
UMass Team Highlights Cannabis Industry Capital Allocation Issues
The cannabis industry capital allocation heavily favors product development over medical research. This imbalance creates a gap in clinical evidence that affects patient care. UMass researchers emphasize the need for better funding distribution to…
Missouri Advances State-Licensed Cannabis Research Initiatives
State-licensed cannabis research programs in Missouri aim to accelerate clinical evidence generation by bypassing federal restrictions. These programs enable rigorous studies on cannabis efficacy and safety. Missouri's initiative could provide valuable…